HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin Wolter Selected Research

Selective Estrogen Receptor Modulators (SERM)

11/2010Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin Wolter Research Topics

Disease

1Hemorrhage
01/2018
1Chronic Kidney Failure (Chronic Renal Failure)
01/2018
1Osteoporosis
11/2010
1Stroke (Strokes)
11/2010
1Metabolic Bone Diseases (Osteopenia)
11/2010
1Breast Neoplasms (Breast Cancer)
11/2010
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2010

Drug/Important Bio-Agent (IBA)

1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2018
1AnticoagulantsIBA
01/2018
1Dalteparin (Dalteparin Sodium)FDA Link
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
1Estrogen ReceptorsIBA
11/2010
1Sex Hormone-Binding GlobulinIBA
11/2010
1LasofoxifeneIBA
11/2010
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2010
1Estradiol (Delestrogen)FDA LinkGeneric
11/2010